Drug Trial Radar · NCT05587309
A Study to Evaluate the Efficacy and Safety of BLI5100 in Patients With Erosive Esophagitis
Last checked: Nov 19, 2026Latest source record: Jun 16, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,250
Actual
Start
Oct 30, 2022
Primary completion
Jun 16, 2025
Study completion Jun 16, 2025
Sponsor
- Lead sponsor
- Braintree LaboratoriesIndustry
- Sponsor type
- Industry
- First posted
- Oct 20, 2022
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 85 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The objective of the Healing Phase of the study is to evaluate the safety and efficacy of up to 8 weeks of once daily oral administration of BLI5100 versus a PPI control in healing EE. The objective of the Maintenance Phase of the study is to evaluate the safety and efficacy of 24 weeks of once daily oral administration of BLI5100 (low or high dose) versus a PPI control in the maintenance of healed EE.
Conditions
- Erosive Esophagitis
Interventions
BLI5100Drug
Orally via tablet
PPI ControlDrug
Orally via tablet
Primary outcomes
What the sponsor says the trial is designed to measure.
- Healing Phase: Percentage of patients with complete healing by Week 8.Time frame: 8 Weeks
- Maintenance Phase: Percentage of patients who maintain complete healing through Week 24.Time frame: 24 Weeks
Locations
122 sites in 1 country. Site status is shown where the registry gives one.
Research Site 145
Homewood, Alabama
Research Site 24
Huntsville, Alabama
Research Site 132
Peoria, Arizona
Research Site 150
Peoria, Arizona
Research Site 62
Phoenix, Arizona
Research Site 27
Tucson, Arizona
Research Site 87
Little Rock, Arkansas
Research Site 117
North Little Rock, Arkansas
Research Site 51
Arcadia, California
Research Site 66
Bell Gardens, California
Research Site 156
Camarillo, California
Research Site 19
Canoga Park, California
Research Site 94
Chula Vista, California
Research Site 10
Huntington Park, California
Research Site 55
La Mesa, California
Research Site 72
Los Angeles, California
Research Site 14
San Diego, California
Research Site 85
Santa Ana, California
Research Site 13
Santa Ana, California
Research Site 41
Santa Maria, California
Research Site 54
Westlake, California
Research Site 89
Littleton, Colorado
Research Site 147
Bristol, Connecticut
Research Site 74
Boca Raton, Florida
Research Site 108
Cooper City, Florida
Research Site 91
Doral, Florida
Research Site 03
Hialeah, Florida
Research Site 78
Homestead, Florida
Research Site 09
Lake City, Florida
Research Site 23
Maitland, Florida
Research Site 38
Miami, Florida
Research Site 43
Miami, Florida
Research Site 67
Miami, Florida
Research Site 92
Miami, Florida
Research Site 31
Miami, Florida
Research Site 71
Miami, Florida
Research Site 42
Miami Lakes, Florida
Research Site 17
New Port Richey, Florida
Research Site 90
Ocoee, Florida
Research Site 107
Orlando, Florida
Showing 40 of 122 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.